BridgeMD
Tests treatment safety and results for Depressive Disorder, Major
Official title Effectiveness of an Ecological Momentary Emotion Regulation Intervention
ClinicalTrials.gov ID: NCT06311136
What this study is testing
- What it's testing
- This two-armed randomized controlled trial aims to investigate the effectiveness of an emotion regulation intervention in individuals with and without depressive disorders. The study encompasses participants diagnosed with mild to moderate major depression or persistent depressive disorder and healthy controls without a current depressive disorder.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Online consent for participation
- Adequate proficiency in the German language, encompassing both reading and comprehension skills
- Ownership of a smartphone, compatible with either Android or iOS operating systems, and access to the Internet For individuals in the clinical group...
- Currently meeting the DSM-5 criteria for a mild or moderate major depressive episode, or persistent depressive disorder
You likely can't join if
- Current severe substance use disorder
- Acute suicidality
- Current severe major depressive episode
- Lifetime bipolar disorder
- Lifetime psychotic disorders For the control group, additional exclusion criteria include:
- Meeting the DSM-5 criteria for a major depressive episode within the last 12 months
See the full eligibility criteria
- Online consent for participation
- Adequate proficiency in the German language, encompassing both reading and comprehension skills
- Ownership of a smartphone, compatible with either Android or iOS operating systems, and access to the Internet For individuals in the clinical group with current depressive disorders:
- Currently meeting the DSM-5 criteria for a mild or moderate major depressive episode, or persistent depressive disorder
- Current severe substance use disorder
- Acute suicidality
- Current severe major depressive episode
- Lifetime bipolar disorder
- Lifetime psychotic disorders For the control group, additional exclusion criteria include:
- Meeting the DSM-5 criteria for a major depressive episode within the last 12 months
- History of severe major depressive episodes
- Recurrent depressive disorder
- History of persistent depressive disorder
- Current treatment (psychotherapy, pharmacotherapy) for depressive symptoms
The study team makes the final eligibility decision.
Where it's taking place
- Heidelberg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Heidelberg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.